David Malcom Rodman's Net Worth
$4.12 Million
Who is David Malcom Rodman?
David Malcom Rodman has an estimated net worth of $4.12 Million. This is based on reported shares across multiple companies, which include Mineralys Therapeutics, Inc., and Nivalis Therapeutics, Inc..
SEC CIK
David Malcom Rodman's CIK is 0001672659
Past Insider Trading and Trends
2024 was David Malcom Rodman's most active year for acquiring shares with 19 total transactions. David Malcom Rodman's most active month to acquire stocks was the month of July. 2024 was David Malcom Rodman's most active year for disposing of shares, totalling 20 transactions. David Malcom Rodman's most active month to dispose stocks was the month of July. 2023 saw David Malcom Rodman paying a total of $177,102.18 for 375,971 shares, this is the most they've acquired in one year. In 2023 David Malcom Rodman cashed out on 483,501 shares for a total of $2,994,400.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mineralys Therapeutics, Inc. (MLYS) Snapshot price: $11.23
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.06 | -$355,545.25 | 135.97K |
Scheduled
|
Nov 6
| ||
Form 4
| +8.26% | 10.37K |
$0.82 | $8,489.34 | 135.97K |
Oct 11 - Oct 14
| |||
Form 4
| +9.95% | 11.37K |
$0.84 | $9,566.64 | 125.61K |
Sep 11 - Sep 12
| |||
Form 4
| +11.05% | 11.37K |
$0.84 | $9,565.02 | 114.24K |
Aug 12
| |||
Form 4
|
—
|
0
|
$8.04 | -$7,308.58 | 102.87K |
Scheduled
|
Jul 16
| ||
Form 4
| +12.42% | 11.37K |
$0.84 | $9,566.10 | 102.87K |
Jul 11 - Jul 12
| |||
Form 4
| +14.50% | 11.37K |
$0.84 | $9,566.10 | 89.73K |
Jun 11 - Jun 12
| |||
Form 4
| +16.96% | 11.37K |
$0.84 | $9,565.56 | 78.36K |
May 13
| |||
Form 4
|
—
|
0
|
$8.04 | -$1,392.00 | 67K |
Scheduled
|
May 9
| ||
Form 4
| +20.43% | 11.37K |
$0.84 | $9,566.10 | 67K |
Apr 11 - Apr 12
| |||
Form 4
| +25.67% | 11.37K |
$0.84 | $9,565.02 | 55.63K |
Mar 11 - Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +34.55% | 11.37K |
$0.84 | $9,566.10 | 44.27K |
Feb 12
| |||
Form 4
| +52.77% | 11.37K |
$0.84 | $9,565.02 | 32.9K |
Jan 11 - Jan 12
| |||
Form 4
| +33.34% | 5.02K |
$0.54 | $2,709.72 | 20.07K |
Dec 11
| |||
Form 4
| +50.00% | 5.02K |
$0.54 | $2,709.18 | 15.05K |
Nov 13
| |||
Form 4
|
∞
| 10.03K |
$0.54 | $5,418.36 | 10.03K |
Nov 3
| |||
Form 4
|
—
|
0
|
$6.82 | -$2,828,135.79 |
0
|
Aug 10 - Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nivalis Therapeutics, Inc. (ALPN) No price found
Exec Vice President and CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 11.37K |
$2.27 | -$15,179.49 | 11.37K |
Scheduled
|
Jan 3 - Jan 4
| ||
Form 4
|
∞
| 12.24K |
$7.96 | -$46,327.20 | 12.24K |
Scheduled
|
Oct 3 - Oct 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
∞
| 12.11K |
$4.66 | -$27,727.00 | 12.11K |
Scheduled
|
Jul 1 - Jul 5
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||